Faster FHV-1 testing may move closer to the clinic: full analysis
A new feline herpesvirus 1 diagnostic study adds to the push for faster, simpler molecular testing in companion animal practice. In a paper published in Animals, investigators describe a closed one-tube colorimetric and fluorescent LAMP assay designed to detect FHV-1 in 40 minutes at 63 °C, using the viral thymidine kinase gene as the target. The closed-tube design matters because it aims to limit post-amplification handling, a known source of contamination in isothermal assays. (pubmed.ncbi.nlm.nih.gov)
The clinical backdrop is familiar to veterinarians. FHV-1 remains one of the core pathogens in feline upper respiratory disease complexes and is especially relevant in shelters, breeding environments, and multicat households. It can cause acute respiratory disease, conjunctivitis, keratitis, and recurrent ocular disease, while latent infection in the trigeminal ganglion means cats may shed virus intermittently after apparent recovery. That biology is one reason FHV-1 diagnostics have always required careful interpretation. (vet.cornell.edu)
According to the study summary, the new assay combines two readout modes in the same sealed tube: cresol red for naked-eye color change and EvaGreen for fluorescence. The authors report that the assay targets the TK gene, completes amplification within 40 minutes, and is intended to provide a rapid alternative to conventional molecular workflows. The TK target is not new in FHV-1 diagnostics; earlier PCR work also used the thymidine kinase gene to detect active and latent infections, which gives the new assay some continuity with established molecular approaches. (pmc.ncbi.nlm.nih.gov)
There’s broader industry context here, too. LAMP platforms are already being explored across veterinary virology because they can run at a constant temperature and may be easier to deploy outside a full molecular lab. Similar work has been published for feline coronavirus, bovine herpesvirus 1, equine herpesvirus, and other animal pathogens, often with the same pitch: faster turnaround, lower equipment burden, and potential field or clinic use. That doesn’t guarantee adoption, but it does show that veterinary diagnostics developers are steadily moving toward simpler nucleic acid tests. (mdpi.com)
Independent expert reaction specifically to this paper was limited in publicly available sources at the time of reporting. Still, existing feline herpesvirus guidance offers a useful reality check. The ABCD guidelines caution that positive PCR results can reflect low-level shedding or latency rather than active causation, and broader reviews of feline molecular diagnostics make the same point: a PCR-positive cat may be a carrier, not necessarily a cat whose current respiratory or ocular disease is being driven by FHV-1. (pubmed.ncbi.nlm.nih.gov)
Why it matters: If the assay performs well outside the research setting, it could be useful for faster decision-making in general practice, emergency settings, and shelters, where time, equipment, and isolation space all matter. A quicker molecular answer could help veterinarians sort suspected infectious respiratory cases, support outbreak response, and communicate more clearly with pet parents about likely causes and next steps. But this is best viewed as a workflow advance, not a standalone clinical answer. In feline upper respiratory disease, test interpretation still depends on sample quality, sampling site, coinfections, vaccination history, clinical signs, and the possibility of latent herpesvirus shedding. Prior studies suggest that sampling strategy matters, with combinations such as oropharyngeal plus conjunctival or nasal swabs improving detection of respiratory pathogens. (pubmed.ncbi.nlm.nih.gov)
What to watch: The next milestones are external validation, head-to-head comparisons with standard real-time PCR in clinical populations, and evidence on performance in shelters or first-opinion practice. It will also be worth watching whether the assay is commercialized or adapted into broader feline respiratory panels, since single-pathogen speed is most useful when it fits into real diagnostic workflows. That last point is an inference based on current market direction in veterinary molecular testing, rather than a claim made by the paper itself. (pmc.ncbi.nlm.nih.gov)